The overall aim of this project is to investigate the actions of psychotogenic drugs within the framework of the basic electrophysiological and anatomical properties of central serotonergic and noradrenergic systems. This work has mental health relevance in terms of promoting an understanding of brain systems that may be disturbed in naturally occurring psychoses. Specific research proposals are: 1. To study the ionic mechanisms underlying pacemaker properties of serotonergic dorsal raphe neurons. Ionic conductances in the pacemaker cycle are to be studied in brain slices and the effects of LSD, serotonin, and alpha-1-agonists will be tested. 2. To study the effects of L-tryptophan infusions on autoreceptor regulation of serotonergic neurons in brain slices. Light and electron immunohistochemical as well as electrophysiological experiments are planned in conjunction with L-tryptophan infusions. 3. To investigate intrinsic and extrinsic factors in the regulation of noradrenergic locus coeruleus in brain slices. The regulatory role of intrinsic ionic conductances, extrinsic transmitter inputs, and the effects of hallucinogenic drugs are to be explored. 4. To investigate the ionic mechanisms underlying the facilitatory effects of alpha-1-adrenoceptors. The effects of indoleamine and phenethylamine hallucingens on alpha-1-receptor mediated effects are to be investigated in various brain regions. 5. To study the interaction of hallucinogenic drugs with putative serotonin-2 receptors in prefrontal. The effects of serotonin-2 antagonists on hallucinogenic drug responses will be examined by iontophoretic techniques in vivo. 6. To study cellular mechanisms of tolerance and sensitization to hallucinogenic drugs. Receptor effects are to be examined by means of in vitro recordings following a tolerance schedule of in vivo drug injection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH017871-17
Application #
3374723
Study Section
(BPNA)
Project Start
1975-04-01
Project End
1990-03-31
Budget Start
1986-04-01
Budget End
1987-03-31
Support Year
17
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Abdallah, Chadi G; Sanacora, Gerard; Duman, Ronald S et al. (2015) Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics. Annu Rev Med 66:509-23
Krystal, John H; Sanacora, Gerard; Duman, Ronald S (2013) Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond. Biol Psychiatry 73:1133-41
Liu, Rong-Jian; Lee, Francis S; Li, Xiao-Yuan et al. (2012) Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex. Biol Psychiatry 71:996-1005
Liu, Rong-Jian; Aghajanian, George K (2008) Stress blunts serotonin- and hypocretin-evoked EPSCs in prefrontal cortex: role of corticosterone-mediated apical dendritic atrophy. Proc Natl Acad Sci U S A 105:359-64
Lambe, E K; Aghajanian, G K (2007) Prefrontal cortical network activity: Opposite effects of psychedelic hallucinogens and D1/D5 dopamine receptor activation. Neuroscience 145:900-10
Aghajanian, G K (1994) Electrophysiological studies on the actions of hallucinogenic drugs at 5-HT2 receptors in rat brain. NIDA Res Monogr 146:183-202
Gellman, R L; Aghajanian, G K (1994) Serotonin2 receptor-mediated excitation of interneurons in piriform cortex: antagonism by atypical antipsychotic drugs. Neuroscience 58:515-25
Marek, G J; Aghajanian, G K (1994) Excitation of interneurons in piriform cortex by 5-hydroxytryptamine: blockade by MDL 100,907, a highly selective 5-HT2A receptor antagonist. Eur J Pharmacol 259:137-41
Gellman, R L; Aghajanian, G K (1993) Pyramidal cells in piriform cortex receive a convergence of inputs from monoamine activated GABAergic interneurons. Brain Res 600:63-73
Rasmussen, K; Krystal, J H; Aghajanian, G K (1991) Excitatory amino acids and morphine withdrawal: differential effects of central and peripheral kynurenic acid administration. Psychopharmacology (Berl) 105:508-12

Showing the most recent 10 out of 40 publications